Medication Adherence in Heart Failure After Hospitalisation
Completed
- Conditions
- Heart FailureAdherence, Medication
- Registration Number
- NCT05233644
- Lead Sponsor
- University of Zurich
- Brief Summary
To explore medication adherence in patients who were hospitalised due to heart failure.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 72
Inclusion Criteria
- Diagnosis of Heart failure
- Hospitalisation due to heart failure in the past two years
Exclusion Criteria
- Not speaking German
- cognitive impairment
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Medication Adherence at one timepoint (cross sectional) MARS-5 5-Item Medication Adherence Rating Scale
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What genetic polymorphisms influence medication adherence in heart failure patients post-hospitalization (NCT05233644)?
How does observational adherence tracking in NCT05233644 compare to standard-of-care interventions for heart failure management?
Which biomarkers correlate with successful medication adherence in post-hospitalization heart failure cohorts?
What adverse drug events are associated with non-adherence in heart failure therapies studied in NCT05233644?
How do combination therapies like beta-blockers and ARNIs impact adherence outcomes in NCT05233644 heart failure patients?
Trial Locations
- Locations (1)
University Hospital Zurich
🇨🇭Zürich, Switzerland
University Hospital Zurich🇨🇭Zürich, Switzerland